Abcellera Biologics Inc (ABCL) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Abcellera Biologics Inc   (NASDAQ: ABCL)


Abcellera Biologics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Abcellera Biologics Inc's ROI in the second quarter of 2026?
Abcellera Biologics Inc recorded a cumulative net loss of $-165 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -12.86%.

Within the Healthcare sector 256 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2661 to 3092.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -2.17 % -0.12 % -0.92 % -2.9 % -4.29 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,254 1,260 1,306 1,303 1,352
Return On Investment (TTM) -12.86 % -11.03 % -11.16 % -13.14 % -12.65 %
ABCL's Overall Ranking # 3092 # 2661 # 2312 # 2958 # 2567
Seq. Investment Change TTM -1.87 % -0.53 % 0.43 % -0.2 % 0.19 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -165 -144 -146 -172 -166

ABCL Company Profile >> Back to ABCL Roi Comparisons >> See Annual ABCL Return On Investment



Return On Investment ABCL's Ranking
Within: No.
Industry # 91
Sector # 257
Overall # 3092

Return On Investment Statistics
High Average Low
45.08 %
-0.88 %
-12.23 %
(Mar 31 2021)   (Sep 30 2024)







Financial Statements
Abcellera Biologics Inc's II. Quarter Investments $ 1,254 Millions ABCL's Balance sheet
Abcellera Biologics Inc's II. Quarter Income $ -55 Millions Quarterly ABCL's Income Statement
ABCL's Income by Division See ABCL's Income by Division


ABCL Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 1,293 1,284 1,369 1,423 1,063
Y / Y Investment Growth 0.68 % -6.22 % -3.76 % 33.78 % -
Net Income in Millions -146 -163 -146 159 153
Y / Y Net Income Growth - - - 3.29 % -
Annual Return On Investment -11.33 % -12.68 % -10.69 % 11.14 % 14.43 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ABCL's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ABCL's Competitors
Subscribers only: Roi for Abcellera Biologics Inc's Suppliers
Subscribers only: Return On Investment for ABCL's Customers

Other Ratios
ABCL's Roa ABCL's Inventory Turnover Ratio ABCL's Growth Rates ABCL's Dividend Statistics
ABCL's Profitability Ratios ABCL's Asset Turnover Ratio ABCL's Dividend Growth
ABCL's Roe ABCL's Valuation Ratios ABCL's Financial Strength Ratios ABCL's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-09T01:58:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.